Literature DB >> 16568896

Viruses as quasispecies: biological implications.

E Domingo1, V Martin, C Perales, A Grande-Pérez, J García-Arriaza, A Arias.   

Abstract

During viral infections, the complex and dynamic distributions of variants, termed viral quasispecies, play a key role in the adaptability of viruses to changing environments and the fate of the population as a whole. Mutant spectra are continuously and avoidably generated during RNA genome replication, and they are not just a by-product of error-prone replication, devoid of biological relevance. On the contrary, current evidence indicates that mutant spectra contribute to viral pathogenesis, can modulate the expression of phenotypic traits by subpopulations of viruses, can include memory genomes that reflect the past evolutionary history of the viral lineage, and, furthermore, can participate in viral extinction through lethal mutagenesis. Also, mutant spectra are the target on which selection and random drift act to shape the long-term evolution of viruses. The biological relevance of mutant spectra is the central topic of this chapter.

Entities:  

Mesh:

Year:  2006        PMID: 16568896      PMCID: PMC7120838          DOI: 10.1007/3-540-26397-7_3

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  86 in total

Review 1.  Ribavirin--current status of a broad spectrum antiviral agent.

Authors:  N J Snell
Journal:  Expert Opin Pharmacother       Date:  2001-08       Impact factor: 3.889

Review 2.  Mutation rate and the efficacy of antimicrobial drug treatment.

Authors:  Philip J Gerrish; J Gerardo García-Lerma
Journal:  Lancet Infect Dis       Date:  2003-01       Impact factor: 25.071

3.  Suppression of viral infectivity through lethal defection.

Authors:  Ana Grande-Pérez; Ester Lázaro; Pedro Lowenstein; Esteban Domingo; Susanna C Manrubia
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

Review 4.  Introduction and history of foot-and-mouth disease virus.

Authors:  B W J Mahy
Journal:  Curr Top Microbiol Immunol       Date:  2005       Impact factor: 4.291

5.  A mutation in tomato aspermy cucumovirus that abolishes cell-to-cell movement is maintained to high levels in the viral RNA population by complementation.

Authors:  I M Moreno; J M Malpica; E Rodríguez-Cerezo; F García-Arenal
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy.

Authors:  J M Coffin
Journal:  Science       Date:  1995-01-27       Impact factor: 47.728

7.  Self-replication with errors. A model for polynucleotide replication.

Authors:  J Swetina; P Schuster
Journal:  Biophys Chem       Date:  1982-12       Impact factor: 2.352

8.  Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons.

Authors:  J G Garcia-Lerma; S Nidtha; K Blumoff; H Weinstock; W Heneine
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

9.  Immunity in chimpanzees chronically infected with hepatitis C virus: role of minor quasispecies in reinfection.

Authors:  C A Wyatt; L Andrus; B Brotman; F Huang; D H Lee; A M Prince
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

10.  Synchronous loss of quasispecies memory in parallel viral lineages: a deterministic feature of viral quasispecies.

Authors:  Carmen M Ruiz-Jarabo; Eric Miller; Gema Gómez-Mariano; Esteban Domingo
Journal:  J Mol Biol       Date:  2003-10-24       Impact factor: 5.469

View more
  99 in total

1.  Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing.

Authors:  Daniele Armenia; Ina Vandenbroucke; Lavinia Fabeni; Herwig Van Marck; Valeria Cento; Roberta D'Arrigo; Liesbeth Van Wesenbeeck; Fernanda Scopelliti; Valeria Micheli; Bianca Bruzzone; Sergio Lo Caputo; Jeroen Aerssens; Giuliano Rizzardini; Valerio Tozzi; Pasquale Narciso; Andrea Antinori; Lieven Stuyver; Carlo Federico Perno; Francesca Ceccherini-Silberstein
Journal:  J Infect Dis       Date:  2012-01-11       Impact factor: 5.226

2.  Competition-colonization trade-off promotes coexistence of low-virulence viral strains.

Authors:  Samuel Ojosnegros; Edgar Delgado-Eckert; Niko Beerenwinkel
Journal:  J R Soc Interface       Date:  2012-04-18       Impact factor: 4.118

Review 3.  Prions on the move.

Authors:  Charles Weissmann; Jiali Li; Sukhvir P Mahal; Shawn Browning
Journal:  EMBO Rep       Date:  2011-10-28       Impact factor: 8.807

4.  Massively parallel sequencing for monitoring genetic consistency and quality control of live viral vaccines.

Authors:  Alexander Neverov; Konstantin Chumakov
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

5.  Structural basis for active site closure by the poliovirus RNA-dependent RNA polymerase.

Authors:  Peng Gong; Olve B Peersen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-10       Impact factor: 11.205

6.  Mutagenesis-induced, large fitness variations with an invariant arenavirus consensus genomic nucleotide sequence.

Authors:  Ana Grande-Pérez; Gema Gómez-Mariano; Pedro R Lowenstein; Esteban Domingo
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 7.  Viruses as anticancer drugs.

Authors:  Stephen J Russell; Kah-Whye Peng
Journal:  Trends Pharmacol Sci       Date:  2007-06-18       Impact factor: 14.819

8.  The 30th anniversary of quasispecies. Meeting on 'Quasispecies: past, present and future'.

Authors:  Esteban Domingo; Simon Wain-Hobson
Journal:  EMBO Rep       Date:  2009-04-03       Impact factor: 8.807

9.  Hidden virulence determinants in a viral quasispecies in vivo.

Authors:  Marta Sanz-Ramos; Fayna Díaz-San Segundo; Cristina Escarmís; Esteban Domingo; Noemí Sevilla
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

Review 10.  New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis.

Authors:  Konstantin Chumakov; Ellie Ehrenfeld
Journal:  Clin Infect Dis       Date:  2008-12-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.